- Sputnik International, 1920
Russia
The latest news and stories from Russia. Stay tuned for updates and breaking news on defense, politics, economy and more.

EMA Experts Positively Evaluate Sputnik V Production Standards, Vaccine Developer Says

© REUTERS / DADO RUVICA vial labelled "Sputnik V coronavirus disease (COVID-19) vaccine" is seen in this illustration picture taken on 2 May 2021.
A vial labelled Sputnik V coronavirus disease (COVID-19) vaccine is seen in this illustration picture taken on 2 May 2021. - Sputnik International, 1920, 11.01.2022
Subscribe
International
India
Africa
MOSCOW (Sputnik) - The European Medicines Agency (EMA) experts have positively evaluated production standards for Sputnik V COVID-19 vaccine, Denis Logunov, the deputy head of the Gamaleya Research Centre, said on Tuesday.
"Regarding how the production standards are recognised, work is underway here, because after all, production standards in Europe, China and Russia must be harmonised, and this part of the work is to recognise production standards, the recognition of how clinical trials were carried out … the EMA has already arrived and we have no critical remarks regarding the conduct of clinical trials, we received a positive conclusion," Logunov told the Soloviev Live Youtube channel.
Sputnik V has been under review by the EMA since March 2021. Hungary and Slovakia approved the vaccine without waiting for EMA authorisation.
A vial labelled Sputnik V coronavirus disease (COVID-19) vaccine is seen in this illustration picture taken on 2 May 2021. - Sputnik International, 1920, 28.12.2021
Russia
Sputnik V Developers to Putin: Trials Show the Russian Vaccine Neutralises Omicron Strain
Sputnik V, the world's first registered vaccine against the COVID-19 infection, was unveiled on 11 August 2020, following Phase 1 and 2 clinical trials. Phase 3 clinical trial results were published in the Lancet magazine on 2 February 2021. The vaccine is based on a well-studied human adenovirus vector platform. The efficacy of Sputnik V has been proven at 97.6%, based on the analysis of data on the occurrence of the COVID-19 infection among Russians vaccinated with both components from December 2020 to late March 2021.
Sputnik V has already been authorised in 71 countries with a total population of more than 4 billion people.
Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала